Kyuho Jeong1, Jung-Hyun Kim2, James M Murphy1, Hyeonsoo Park1, Su-Jeong Kim1, Yelitza A R Rodriguez1, Hyunkyung Kong2, Chungsik Choi3, Jun-Lin Guan4, Joan M Taylor5, Thomas M Lincoln3, William T Gerthoffer1, Jun-Sub Kim1,6, Eun-Young Erin Ahn1,2, David D Schlaepfer7, Ssang-Taek Steve Lim1. 1. From the Department of Biochemistry and Molecular Biology (K.J., J.M.M., H.P., S.-J.K., Y.A.R.R., W.T.G., J.-S.K., E.-Y.E.A., S.-T.S.L.), University of South Alabama, College of Medicine, Mobile. 2. Mitchell Cancer Institute (J.-H.K., H.K., E.-Y.E.A), University of South Alabama, College of Medicine, Mobile. 3. Department of Physiology (C.C., T.M.L.), University of South Alabama, College of Medicine, Mobile. 4. Department of Cancer Biology, University of Cincinnati, College of Medicine, OH (J.-L.G.). 5. Department of Pathology, University of North Carolina, School of Medicine, Chapel Hill (J.M.T.). 6. Department of Biotechnology, Korea National Transportation University, Chungbuk (J.-S.K.). 7. Department of Reproductive Medicine, Moores Cancer Center, University of California, San Diego, La Jolla (D.D.S.).
Abstract
RATIONALE: Neointimal hyperplasia is characterized by excessive accumulation of vascular smooth muscle cells (SMCs) leading to occlusive disorders, such as atherosclerosis and stenosis. Blood vessel injury increases growth factor secretion and matrix synthesis, which promotes SMC proliferation and neointimal hyperplasia via FAK (focal adhesion kinase). OBJECTIVE: To understand the mechanism of FAK action in SMC proliferation and neointimal hyperplasia. METHODS AND RESULTS: Using combined pharmacological FAK catalytic inhibition (VS-4718) and SMC-specific FAK kinase-dead (Myh11-Cre-ERT2) mouse models, we report that FAK regulates SMC proliferation and neointimal hyperplasia in part by governing GATA4- (GATA-binding protein 4) cyclin D1 signaling. Inhibition of FAK catalytic activity facilitates FAK nuclear localization, which is required for proteasome-mediated GATA4 degradation in the cytoplasm. Chromatin immunoprecipitation identified GATA4 binding to the mouse cyclin D1 promoter, and loss of GATA4-mediated cyclin D1 transcription diminished SMC proliferation. Stimulation with platelet-derived growth factor or serum activated FAK and redistributed FAK from the nucleus to cytoplasm, leading to concomitant increase in GATA4 protein and cyclin D1 expression. In a femoral artery wire injury model, increased neointimal hyperplasia was observed in parallel with elevated FAK activity, GATA4 and cyclin D1 expression following injury in control mice, but not in VS-4718-treated and SMC-specific FAK kinase-dead mice. Finally, lentiviral shGATA4 knockdown in the wire injury significantly reduced cyclin D1 expression, SMC proliferation, and neointimal hyperplasia compared with control mice. CONCLUSIONS: Nuclear enrichment of FAK by inhibition of FAK catalytic activity during vessel injury blocks SMC proliferation and neointimal hyperplasia through regulation of GATA4-mediated cyclin D1 transcription.
RATIONALE: Neointimal hyperplasia is characterized by excessive accumulation of vascular smooth muscle cells (SMCs) leading to occlusive disorders, such as atherosclerosis and stenosis. Blood vessel injury increases growth factor secretion and matrix synthesis, which promotes SMC proliferation and neointimal hyperplasia via FAK (focal adhesion kinase). OBJECTIVE: To understand the mechanism of FAK action in SMC proliferation and neointimal hyperplasia. METHODS AND RESULTS: Using combined pharmacological FAK catalytic inhibition (VS-4718) and SMC-specific FAK kinase-dead (Myh11-Cre-ERT2) mouse models, we report that FAK regulates SMC proliferation and neointimal hyperplasia in part by governing GATA4- (GATA-binding protein 4) cyclin D1 signaling. Inhibition of FAK catalytic activity facilitates FAK nuclear localization, which is required for proteasome-mediated GATA4 degradation in the cytoplasm. Chromatin immunoprecipitation identified GATA4 binding to the mousecyclin D1 promoter, and loss of GATA4-mediated cyclin D1 transcription diminished SMC proliferation. Stimulation with platelet-derived growth factor or serum activated FAK and redistributed FAK from the nucleus to cytoplasm, leading to concomitant increase in GATA4 protein and cyclin D1 expression. In a femoral artery wire injury model, increased neointimal hyperplasia was observed in parallel with elevated FAK activity, GATA4 and cyclin D1 expression following injury in control mice, but not in VS-4718-treated and SMC-specific FAK kinase-dead mice. Finally, lentiviral shGATA4 knockdown in the wire injury significantly reduced cyclin D1 expression, SMC proliferation, and neointimal hyperplasia compared with control mice. CONCLUSIONS: Nuclear enrichment of FAK by inhibition of FAK catalytic activity during vessel injury blocks SMC proliferation and neointimal hyperplasia through regulation of GATA4-mediated cyclin D1 transcription.
Authors: M Sata; Y Maejima; F Adachi; K Fukino; A Saiura; S Sugiura; T Aoyagi; Y Imai; H Kurihara; K Kimura; M Omata; M Makuuchi; Y Hirata; R Nagai Journal: J Mol Cell Cardiol Date: 2000-11 Impact factor: 5.000
Authors: David F Chang; Narasimhaswamy S Belaguli; Dinakar Iyer; Wilmer B Roberts; San-Pin Wu; Xiu-Rong Dong; Joseph G Marx; Mary Shannon Moore; Mary C Beckerle; Mark W Majesky; Robert J Schwartz Journal: Dev Cell Date: 2003-01 Impact factor: 12.270
Authors: Heather A Walker; John M Whitelock; Pamela J Garl; Raphael A Nemenoff; Kurt R Stenmark; Mary C M Weiser-Evans Journal: Mol Biol Cell Date: 2003-01-26 Impact factor: 4.138
Authors: Kyuho Jeong; James M Murphy; Jung-Hyun Kim; Pamela Moore Campbell; Hyeonsoo Park; Yelitza A R Rodriguez; Chung-Sik Choi; Jun-Sub Kim; Sangwon Park; Hyun Joon Kim; Jonathan G Scammell; David S Weber; Richard E Honkanen; David D Schlaepfer; Eun-Young Erin Ahn; Ssang-Taek Steve Lim Journal: Circ Res Date: 2021-10-27 Impact factor: 17.367
Authors: Alexandra C Finney; Matthew L Scott; Kaylea A Reeves; Dongdong Wang; Mabruka Alfaidi; Jake C Schwartz; Connor M Chitmon; Christina H Acosta; James M Murphy; J Steven Alexander; Christopher B Pattillo; Ssang-Taek Lim; A Wayne Orr Journal: Matrix Biol Date: 2021-09-17 Impact factor: 10.447
Authors: James M Murphy; Kyuho Jeong; Donna L Cioffi; Pamela Moore Campbell; Hanjoong Jo; Eun-Young Erin Ahn; Ssang-Taek Steve Lim Journal: Inflammation Date: 2021-02-02 Impact factor: 4.657
Authors: James M Murphy; Yelitza A R Rodriguez; Kyuho Jeong; Eun-Young Erin Ahn; Ssang-Taek Steve Lim Journal: Exp Mol Med Date: 2020-06-09 Impact factor: 8.718